Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers-Reference-Cited by-同舟云学术

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

Published:1998-08 Issue:2 Volume:46 Page:111-116
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Ouellet* Daniele¹,Hsu Ann¹,Qian Jiang¹,Locke Charles S.¹,Eason Carolyn J.¹,Cavanaugh John H.¹,Leonard John M.¹,Granneman G. Richard¹

Affiliation:

1. Abbott Laboratories, Abbott Park, IL, 60064–3500, U.S.A

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1998.00749.x

Reference29 articles.

1. HIV protease inhibitors: their anti‐HIV activity and potential role in treatment.;Robins T;J Acquir Immune Defic Syndr,1993

2. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

3. A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease

4. Cytochrome P450‐mediated metabolism of the HIV‐1 protease inhibitor ritonavir (ABT‐538) in human liver microsomes.;Kumar GN;J Pharmacol Exp Ther,1996

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions;CPT: Pharmacometrics & Systems Pharmacology;2024-01-15

2. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

3. Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19;Therapeutic Drug Monitoring;2023-04

4. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24

5. Global Challenges with Oral Antivirals for COVID-19;Population Health Management;2022-12-01